The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Africa is
poorly described. The first case of SARS-CoV-2 in Kenya was reported on 12 March 2020, …

Investment in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing
in Africa over the past year has led to a major increase in the number of sequences that have …

Policy decisions on COVID-19 interventions should be informed by a local, regional and
national understanding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Natural killer (NK) cells are potent immune effectors that can be activated via antibody-mediated
Fc receptor engagement. Using multiparameter flow cytometry, we found that NK cells …

Background Few studies have assessed the seroprevalence of antibodies against severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among healthcare workers (HCWs) …

Genomic surveillance of SARS-CoV-2 is important for understanding both the evolution and
the patterns of local and global transmission. Here, we generated 311 SARS-CoV-2 …

Background A few studies have assessed the epidemiological impact and the cost-effectiveness
of COVID-19 vaccines in settings where most of the population had been exposed to …

BACKGROUND Naturally acquired immunity to malaria is incompletely understood. We used
controlled human malaria infection (CHMI) to study the impact of past exposure on malaria …

Introduction The high proportion of SARS-CoV-2 infections that have remained undetected
presents a challenge to tracking the progress of the pandemic and estimating the extent of …

Policymakers in Africa need robust estimates of the current and future spread of SARS-CoV-2.
We used national surveillance PCR test, serological survey and mobility data to develop …